Company profile for Scientis

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Scientis is a privately held specialty dermatology company located in Geneva, Switzerland. Dedicated to skin pigmentation concerns, achievements have resulted in the discovery of novel active ingredients and procedures. Innovation projects are focused on melanogenesis inhibitors and inducers, and diagnostic and therapeutic devices in the field of skin pigmentation. Cyspera® is its leading product and it is the first pigment c...
Scientis is a privately held specialty dermatology company located in Geneva, Switzerland. Dedicated to skin pigmentation concerns, achievements have resulted in the discovery of novel active ingredients and procedures. Innovation projects are focused on melanogenesis inhibitors and inducers, and diagnostic and therapeutic devices in the field of skin pigmentation. Cyspera® is its leading product and it is the first pigment corrector formulated with cysteamine to address the appearance of discoloration and dark spots.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Switzerland
Address
Address
Campus Biotech, EPFL Innovation Park, Gen?ve, CH 1202
Telephone
Telephone
+41 791071202
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251001739674/en/Noetik-Expands-Scientific-Advisory-Board-to-Build-the-Future-of-Cancer-Therapeutics

BUSINESSWIRE
01 Oct 2025

https://www.businesswire.com/news/home/20241223615902/en

BUSINESSWIRE
23 Dec 2024

https://www.globenewswire.com/news-release/2024/12/10/2994688/0/en/Brain-Cancer-Canada-Awards-a-50-000-Grant-to-Discover-How-to-Use-the-Body-s-Own-Immune-Cells-to-Attack-Pediatric-Brain-Cancers.html

GLOBENEWSWIRE
10 Dec 2024

https://www.globenewswire.com/news-release/2024/12/03/2990829/0/en/Brain-Cancer-Canada-a-leading-advocate-in-the-fight-against-brain-cancer-is-proud-to-award-a-100-000-research-grant-to-one-of-Canada-s-top-neuropathologists-to-support-research-on-.html

GLOBENEWSWIRE
03 Dec 2024

https://www.prnewswire.com/news-releases/cistto-launches-the-humanized-anti-aging-global-scientist-alliance-in-china-empowering-products-with-cutting-edge-science-302314316.html

PR NEWSWIRE
25 Nov 2024
iSpecimen Reports Q3 2024 Results
iSpecimen Reports Q3 2024 Results

07 Nov 2024

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2024/11/07/2976491/0/en/iSpecimen-Reports-Third-Quarter-2024-Results.html

GLOBENEWSWIRE
07 Nov 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty